Certain antibiotics can lower blood sugar, sometimes to dangerous levels. This isn’t a universal effect of all antibiotics, but specific classes, particularly fluoroquinolones like levofloxacin and ciprofloxacin, have a well-documented ability to cause hypoglycemia. The risk climbs significantly if you have diabetes, take insulin or diabetes medications, have kidney problems, or are over 65.
Which Antibiotics Affect Blood Sugar
Fluoroquinolones are the most studied group of antibiotics linked to low blood sugar. These include levofloxacin (Levaquin), ciprofloxacin (Cipro), and moxifloxacin (Avelox). Gatifloxacin, once widely prescribed, was actually pulled from the U.S. market largely because of its blood sugar effects. The FDA has required updated warning labels on all fluoroquinolones, specifically noting that low blood sugar can progress to coma in severe cases.
Trimethoprim-sulfamethoxazole (Bactrim) is another antibiotic that can indirectly lower blood sugar, though through a completely different mechanism. It doesn’t act on blood sugar directly. Instead, it interferes with how your liver processes certain diabetes medications, causing those drugs to build up and work more aggressively than intended.
Clarithromycin, a macrolide antibiotic commonly prescribed for respiratory and sinus infections, has also been linked to severe hypoglycemia in people taking the diabetes drug glibenclamide. Case reports describe dangerously low blood sugar during combined use, likely because clarithromycin increases how much of the diabetes medication stays active in your bloodstream.
How Fluoroquinolones Lower Blood Sugar
Fluoroquinolones can directly stimulate your pancreas to release insulin, even when your blood sugar doesn’t call for it. The mechanism is surprisingly specific. Your pancreatic beta cells (the cells that produce insulin) have potassium channels that act like a gate, controlling when insulin gets released. Certain fluoroquinolones block these channels directly, which triggers insulin release regardless of what your blood sugar is doing at the time.
Research published in the European Journal of Pharmacology showed that gatifloxacin and temafloxacin inhibited these potassium channels in a dose-dependent manner, meaning higher doses caused more insulin release. Levofloxacin had a smaller effect on the channels, but it still carries risk, especially at higher doses or in vulnerable patients. This is essentially the same mechanism used by some diabetes drugs on purpose, which is why the blood sugar drop can be substantial.
The Drug Interaction Problem
The risk of low blood sugar from antibiotics increases dramatically when you’re already taking diabetes medications. This happens through two pathways. First, some antibiotics block the liver enzyme CYP2C9, which is responsible for breaking down common diabetes drugs like glyburide and glipizide. When that enzyme is blocked, the diabetes medication lingers in your system longer and at higher concentrations than expected. Trimethoprim-sulfamethoxazole is a well-known CYP2C9 inhibitor.
Second, fluoroquinolones can stack their own insulin-stimulating effect on top of whatever your diabetes medication is already doing. You end up with two forces pushing your blood sugar down at once. In an FDA surveillance review, cases of severe hypoglycemia were reported in patients taking fluoroquinolones both alone and in combination with sulfonylureas (a class of oral diabetes drugs). The combined cases tended to be more severe, with outcomes including hypoglycemic coma and seizures.
Who Faces the Highest Risk
People with diabetes are the most vulnerable, particularly those on insulin or oral medications that lower blood sugar. In a systematic review of fluoroquinolone safety in diabetic patients, levofloxacin was associated with 579 reported cases of hypoglycemia in diabetic patients, followed by ciprofloxacin with 488 cases and gatifloxacin with 231. These numbers reflect reported adverse events, so the true incidence is likely higher.
Kidney impairment is another major risk factor. Your kidneys help clear both the antibiotic and many diabetes medications from your body. When kidney function declines, these drugs accumulate. One case study described a 65-year-old woman with diabetes, chronic kidney disease, and reduced kidney function who developed persistent, severe hypoglycemia lasting six days while on levofloxacin. Her blood sugar remained dangerously low despite receiving intravenous glucose and steroids, and her insulin levels stayed elevated, confirming the antibiotic was directly stimulating insulin release.
Older adults face compounded risk because they’re more likely to have reduced kidney function, take multiple medications, and have less physiological reserve to recover from a blood sugar crash. The FDA specifically called out elderly patients and those on oral diabetes medications or insulin as groups requiring careful blood sugar monitoring during fluoroquinolone treatment.
Symptoms to Recognize
Antibiotic-induced low blood sugar produces the same symptoms as any hypoglycemic episode: shakiness, sweating, rapid heartbeat, confusion, dizziness, irritability, and hunger. What makes it tricky is that some of these symptoms, especially fatigue, confusion, and feeling generally unwell, overlap with being sick from the infection itself. You might attribute how you’re feeling entirely to the illness and miss the fact that your blood sugar is dropping.
Severe cases can escalate to loss of consciousness, seizures, and coma. The FDA’s review of adverse event reports found cases of hypoglycemic coma, hypoglycemic encephalopathy (brain dysfunction from low sugar), and hypoglycemic seizures across multiple fluoroquinolone antibiotics. Levofloxacin accounted for the largest share of these reports, followed by ciprofloxacin and moxifloxacin.
If you have diabetes and you’re starting a course of fluoroquinolones or Bactrim, checking your blood sugar more frequently than usual is a practical step. Pay attention to any new symptoms that feel different from your infection, particularly sudden sweating, trembling, or mental fogginess that comes on between meals.
What About People Without Diabetes
Antibiotic-induced hypoglycemia is far less common in people without diabetes, but it does happen. Fluoroquinolones can stimulate insulin release from healthy beta cells, which means someone with no history of blood sugar problems could theoretically experience a drop. The risk is much lower because a healthy pancreas typically has feedback mechanisms that compensate, but factors like poor nutrition during illness, reduced food intake, or liver disease can tip the balance.
The systematic review data showed that hypoglycemia reports existed in both diabetic and nondiabetic patients taking fluoroquinolones, though the numbers were heavily weighted toward those with diabetes. If you’re otherwise healthy and taking a standard course of ciprofloxacin or levofloxacin for an infection, the chance of a clinically meaningful blood sugar drop is low, but not zero.
Infection Itself Complicates Blood Sugar
Adding another layer of complexity, infections themselves can push blood sugar in both directions. Your body’s stress response to infection releases hormones like cortisol and adrenaline, which typically raise blood sugar. This is why people with diabetes often see their glucose spike when they’re sick. But severe infections can also cause blood sugar to drop, particularly if you’re not eating well, vomiting, or dealing with sepsis.
This creates a tug-of-war. The infection may be pushing your blood sugar up while the antibiotic is pulling it down. The net result is unpredictable, which is exactly why blood sugar can swing erratically during treatment. For someone with diabetes, this makes the usual approach of adjusting medication doses based on expected patterns much harder. More frequent monitoring is the most reliable way to stay ahead of unexpected drops or spikes during an antibiotic course.